ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO313

Risk-Variant APOL1 Expression in iPSC-Derived Macrophages Increases Cellular Stress and Inflammation

Session Information

Category: Genetic Diseases of the Kidneys

  • 1102 Genetic Diseases of the Kidneys: Non-Cystic


  • Liu, Esther, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Lin, Jennie, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

DNA variants for the APOL1 gene have been linked to a higher risk of developing kidney and cardiovascular disease in individuals with recent African ancestry. APOL1 is expressed endogenously in not only kidney cells but also immune cells such as macrophages. Recent studies show that severe acute inflammatory illness such as COVID-19 increases the likelihood of individuals with the high-risk APOL1 genotype developing glomerulopathy, raising the question of the role of immune cells in APOL1-mediated disease. Therefore, we aim to understand the cellular stress and pro-inflammatory pathways increased by risk variant APOL1 expression in iPSC-derived macrophages (iPSDM).


Induced pluripotent stem cell (iPSC) expressing G0 and G1 variants of APOL1 were generated through CRISPR/Cas9. Macrophages (iPSDM) were differentiated from these iPSC lines. Expression of APOL1 in the cultured iPSDMs, was induced with IFNγ (20 ng/mL). Cytokine expression in the cell culture supernatant was measured by ELISA. Metabolic respiration was measured by Seahorse Mito Stress Test (Agilent).


Upon stimulation with IFNγ, we observed a 4.6-fold decrease in TGF-β secretion (n=3, p<0.001) in G1 iPSDM compared to G0. When polarized to an M1-like phenotype with IFNγ and LPS, IL-1β secretion was 1.4-fold increased (n=3, p<0.005) in G1 iPSDM compared to G0. G1 macrophages also had decreased levels of basal respiration compared to G0 (n=3, p=0.04). However, there was no observed difference in mitochondrial reactive oxygen species as measured by MitoSOX Red staining. Additionally, we observe a decrease in protein levels of LC3-II, an indicator of active autophagy, and a 4.4-fold increase of autophagy substrate P62 levels in G1 macrophages compared to G0.


The findings in our experiments show a significant increase in inflammatory cytokine expression in G1 macrophages and decreased levels of basal respiration and autophagy markers. These results suggest that APOL1 risk variant expression modulates macrophage functions which are relevant to kidney homeostasis and disease.


  • Other NIH Support